Results 221 to 230 of about 365,877 (337)

Preservation of cell-free RNA in percutaneous core-needle biopsy specimens' supernatants from non-small cell lung cancer improves genomic testing performance. [PDF]

J Pathol Clin Res
Xu S, Ma YD, Bie ZX, Huang JY, Li YM, Wang Z, Li XG.   +6 more
europepmc   +1 more source

Intratumoral Bacteria: Accomplices in Cancer Progression and Emerging Therapeutic Targets

Medicine Advances, EarlyView.
Intratumoral bacteria are no longer seen as contaminants but as active contributors to cancer progression, driving therapy resistance and metastasis through metabolic reprogramming, immunomodulation, and metastatic niche formation. This review highlights emerging microbiome‐targeted strategies—including synthetic microbial consortia, engineered ...
Jie Yang, Qingyu Han, Qiang Zhang, Yixin Cao   +3 more
wiley   +1 more source

LINC00973/DTX3L Axis Promotes Non-Small Cell Lung Cancer Progression and Serves as a Therapeutic Target. [PDF]

Smart Med
Chen Y, Qian Y, Shi J, Wang Y, Fu T, Meng S, Wang M, Fu M, Zhang J, Zhang X, Ji R, Gu J, Zhang X, Chen ZS, Ma X, Fang X.   +15 more
europepmc   +1 more source

The Genomic Evolution of Early‐Stage Non‐Small Cell Lung Cancer

Medicine Advances, EarlyView.
This study provides a comprehensive overview of the genomic landscape of early‐stage non‐small cell lung cancer, identifying the 4q12 deletion as a potential exclusive biomarker for the “oncogenic switch” from pre‐invasive to invasive lesions. It delineates that while EGFR and TP53 mutations act as early truncal drivers, the progressive increase in ...
Huatao Tang, Yang Zhang, Haiquan Chen
wiley   +1 more source

Cancer-associated fibroblasts promote osimertinib resistance in non-small cell lung cancer cells via METTL1-mediated NET1 m⁷G modification. [PDF]

Cell Death Dis
Qian Y, Gong Z, Jia Y, Zhang Q, Cao L, Li B, Zhang J, Wang M, Wu X, Xu K.   +9 more
europepmc   +1 more source

Lung, NSCLC

Annals of Oncology, 1998
openaire   +1 more source

A Zosteriform Papular Cutaneous Eruption

JEADV Clinical Practice, EarlyView.
Silvia Borriello, Umberto Santaniello, Astrid Lappi, Paolo Borrelli, Angelo Battaglia, Roberta Patetta, Sophie Frassy, Simone Ribero, Pietro Quaglino   +8 more
wiley   +1 more source

Supplementary Table 8 from Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment

Giorgia Maroni, Indira Krishnan, Roberta Alfieri, Valerie A. Maymi, Nicole Pandell, Eva Csizmadia, Junyan Zhang, Marla Weetall, Art Branstrom, Giulia Braccini, Eva Cabrera San Millán, Barbara Storti, Ranieri Bizzarri, Olivier Kocher, Daniela S. Daniela Sanchez Bassères, Robert S. Welner, Maria Cristina Magli, Ivan Merelli, John G. Clohessy, Azhar Ali, Daniel G. Tenen, Elena Levantini   +21 more
openalex   +1 more source

Current Insights and Future Directions of Multiomic and Spatial-Omic Analysis in Non-Small Cell Lung Cancer. [PDF]

JCO Precis Oncol
Church M, Marshall G, Krebs MG.
europepmc   +1 more source

Clinicopathological characteristics of patients with inoperable non‐small cell lung cancer harboring circulating NRF2 pathway mutations

The Journal of Pathology, EarlyView.
Abstract Lung cancer is the leading cause of global cancer‐related morbidity and mortality, with tobacco smoking as its strongest risk factor. Nuclear factor erythroid 2‐related factor 2 (NRF2) is a redox‐regulated transcription factor frequently dysregulated in non‐small cell lung cancer (NSCLC), leading to aggressive disease and resistance to therapy.
Jouni Härkönen, Satu Tiainen, Jouni Kujala, Linnea Muhonen, Ponnuswamy Mohanasundaram, Tuomas Tikkanen, Ina Pöhner, Tommi Patinen, Simone Adinolfi, Juha P Väyrynen, Päivi Auvinen, Arto Mannermaa, Petri Pölönen, Tuomas Rauramaa, Anna‐Liisa Levonen   +14 more
wiley   +1 more source